PRDM2 and neoplasm: Studies have shown that RIZ1 expression is correlated with tumor progression and treatment response, indicating its potential as a potential therapeutic target and suggesting that the PRDM2 gene further influences brain–tumor development by regulating the proliferation and differentiation of neural cells.